COMBINACION DE INHIBIDORES DE MTP E INHIBIDORES DE HMG-COA REDUCTASA Y SU USO EN MEDICAMETOS
La invención se refiere al use de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención. The inven...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Spanish |
Published |
15.08.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | La invención se refiere al use de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención.
The invention relates to the use of a combination consisting of at least one selected MTP inhibitor (constituent A) and of at least one HMG-CoA reductase inhibitor (constituent B) for fighting cardiovascular diseases. The invention also relates to medicaments containing this combination and to the production thereof. |
---|---|
AbstractList | La invención se refiere al use de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención.
The invention relates to the use of a combination consisting of at least one selected MTP inhibitor (constituent A) and of at least one HMG-CoA reductase inhibitor (constituent B) for fighting cardiovascular diseases. The invention also relates to medicaments containing this combination and to the production thereof. |
Author | RUDI GRUTZMANN ULRICH MULLER HILMA BISCHOFF |
Author_xml | – fullname: RUDI GRUTZMANN – fullname: ULRICH MULLER – fullname: HILMA BISCHOFF |
BookMark | eNrjYmDJy89L5WSIcfb3dfL0c3T29PdTcHFV8PTz8HTydPEPcg0GcX1DAhQwBD183XWd_R0VglxdQp1DHIMdFSIVgkMVQoP9FVz9FHxdXTydHX1dQ_yDeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvIt_gJEBBBgZORoTpwoAVlI0Fg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | DOP2000000022A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_DOP2000000022A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:57:20 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_DOP2000000022A3 |
Notes | Application Number: DO20000000022 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080815&DB=EPODOC&CC=DO&NR=P2000000022A |
ParticipantIDs | epo_espacenet_DOP2000000022A |
PublicationCentury | 2000 |
PublicationDate | 20080815 |
PublicationDateYYYYMMDD | 2008-08-15 |
PublicationDate_xml | – month: 08 year: 2008 text: 20080815 day: 15 |
PublicationDecade | 2000 |
PublicationYear | 2008 |
RelatedCompanies | BAYER AKTIENGESELLSCHAFT |
RelatedCompanies_xml | – name: BAYER AKTIENGESELLSCHAFT |
Score | 2.5912123 |
Snippet | La invención se refiere al use de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | COMBINACION DE INHIBIDORES DE MTP E INHIBIDORES DE HMG-COA REDUCTASA Y SU USO EN MEDICAMETOS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080815&DB=EPODOC&locale=&CC=DO&NR=P2000000022A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1DedytQpAaVvxfVr3R6KdElnJ7QpaycThNGvgSDbsBX_vpdu04GwPCUXOJIjd5dL7gPg3uxkitbNcrmXp7qMGj-VEzzGspa3M91MDCWuSid4fscd688TY1KDj00sTJUn9LtKjogclSK_l5W8Xv49YrHKt7J4SN4RtHgcRBaTNtaxqCNhSKxvOQFnnEqUWoxL_sgK1Paqqaq9B_t4kTYFPzgvfRGXstxWKoMTOAgQ37w8hVpeNOCIbmqvNeDQW395Y3fNfcUZvFHu9Ye-TVH-EeaQoe8OUdJyJKIYelFA_gFd70mm3CYjUWInskObvJJwTMYhJ45PVskdPSfi4TncDZyIujIuc_pLlSnj23vSLqA-X8zzJhBTyTrCTFHiWNNNLe32kljpptlMJOvT1dkltHZhuto9fQ3HK5cJND6NFtTLz6_8BvVymdxW5PwBCyCHbg |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhTnG86FT-mBpS-FdevdXso0iWdrS5NWTuZIIx-DQTZhqv49026TQfC8pRc4EiO3F0uuQ-AO7OVKVo7y-VOnuoy1_ipnPBjLGt5M9PNxFDisnQC9VvuUH8aGaMKfKxjYco8od9lckTOUSnn96KU1_O_RyxS-lYu7pN3Dpo99CKLSGvrWNSRMCTStZyAEYYljC3CJH9gBWpz2VTV3oFdfsk2BT84L10RlzLfVCq9Q9gLOL5pcQSVfFGHGl7XXqvDPl19efPuivsWx_CGGe16vo25_EPEQZ7velzSMk5EMaRRgP4BXfooY2ajgSixE9mhjV5ROETDkCHHR8vkjtSJWHgCtz0nwq7Mlzn-pcqYsM09aadQnc6m-RkgU8lawkxR4ljTTS1td5JYaafZRCTr09XJOTS2YbrYPn0DNTei_XHf858v4WDpPsENUaMB1eLzK7_iOrpIrkvS_gCRl4ph |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINACION+DE+INHIBIDORES+DE+MTP+E+INHIBIDORES+DE+HMG-COA+REDUCTASA+Y+SU+USO+EN+MEDICAMETOS&rft.inventor=RUDI+GRUTZMANN&rft.inventor=ULRICH+MULLER&rft.inventor=HILMA+BISCHOFF&rft.date=2008-08-15&rft.externalDBID=A&rft.externalDocID=DOP2000000022A |